Mitomycin C, Epirubicin and Cisplatin versus Mitomycin C Alone as Therapy for Carcinoma of Unknown Primary Origin

Publisher： Karger

E-ISSN： 1423-0232|55|2|116-121

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.2, 1998-01, pp. : 116-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitomycin C, 5-Fluorouracil, Leucovorin, and Oxaliplatin as a Salvage Therapy for Patients with Cisplatin-Resistant Advanced Gastric Cancer: A Phase I Dose Escalation Trial

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 29-34

Karger

Access to resources Recommend Favorite

Erythroderma as drug eruption induced by intravesical mitomycin C therapy

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 613-614

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effective Salvage Therapy with Carboplatin/Mitomycin C in Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 25, Iss. 3, 2002-07 ,pp. : 249-254

Karger

Access to resources Recommend Favorite

Is mitomycin C useful as an adjuvant therapy in endoscopic treatment of laryngotracheal stenosis?

By  

THE LARYNGOSCOPE, Vol. 125, Iss. 10, 2015-10 ,pp. : 2243-2244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is mitomycin C useful as an adjuvant therapy in endoscopic treatment of laryngotracheal stenosis?

By  

THE LARYNGOSCOPE, Vol. 23-852X, Iss. 10, 2015-10 ,pp. : 2243-2244

John Wiley & Sons Inc

Access to resources Recommend Favorite